Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

143 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above

NCT05568797

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Edegem, Belgium
  • GSK Investigational Site Erpent, Belgium
  • GSK Investigational Site Genk, Belgium
  • GSK Investigational Site Ieper, Belgium
View all 37 locations
View Trial Details
Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

NCT05559476

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Canoga Park, California, United States
  • GSK Investigational Site Colton, California, United States
View all 46 locations
View Trial Details
Completed

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

NCT05964582

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Quality Clinical Research - 10040 Regency Cir - HyperCore - PPDS Site Number : 8400001 Omaha, Nebraska, United States
  • Senders Pediatrics Site Number : 8400002 Cleveland, Ohio, United States
  • Investigational Site Number : 2460002 Helsinki, Finland
  • Investigational Site Number : 2460001 Jarvenpaa, Finland
View all 15 locations
View Trial Details
Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

NCT04841577

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Auckland, New Zealand
  • GSK Investigational Site Auckland, New Zealand
  • GSK Investigational Site Christchurch, New Zealand
  • GSK Investigational Site Havelock North, New Zealand
View all 14 locations
View Trial Details
Completed

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

NCT04138056

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Rochester, New York, United States
  • GSK Investigational Site Seattle, Washington, United States
View Trial Details
Completed

Infection Watch Study

NCT04623047

Conditions
COVID-19 Respiratory Infection, Infections, Influenza Viral Infections, +7 more
Locations
  • Duke University Durham, North Carolina, United States
View Trial Details

Related conditions